These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8068461)

  • 1. Bone cells and matrix bind chemically modified non-antimicrobial tetracycline.
    Sasaki T; Ramamurthy NS; Golub LM
    Bone; 1994; 15(3):373-5. PubMed ID: 8068461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-deficient diabetes impairs osteoblast and periodontal ligament fibroblast metabolism but does not affect ameloblasts and odontoblasts: response to tetracycline(s) administration.
    Sasaki T; Ramamurthy NS; Golub LM
    J Biol Buccale; 1990 Sep; 18(3):215-26. PubMed ID: 2147681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: a quantitative autoradiographic study.
    Sasaki T; Ramamurthy NS; Golub LM
    Calcif Tissue Int; 1992 May; 50(5):411-9. PubMed ID: 1534508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetracycline administration restores osteoblast structure and function during experimental diabetes.
    Sasaki T; Kaneko H; Ramamurthy NS; Golub LM
    Anat Rec; 1991 Sep; 231(1):25-34. PubMed ID: 1836318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability.
    Kirkwood K; Martin T; Andreadis ST; Kim YJ
    Biochem Pharmacol; 2003 Nov; 66(9):1809-19. PubMed ID: 14563491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of MMP-13 by chemical modified tetracyclines in osteoblasts.
    Kirkwood K; Martin T; Agnello K; Kim YJ
    J Int Acad Periodontol; 2004 Apr; 6(2):39-46. PubMed ID: 15125014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
    Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
    J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetracycline administration increases protein (presumably procollagen) synthesis and secretion in periodontal ligament fibroblasts of streptozotocin-induced diabetic rats.
    Sasaki T; Ramamurthy NS; Yu Z; Golub LM
    J Periodontal Res; 1992 Nov; 27(6):631-9. PubMed ID: 1460549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chemically modified tetracycline, CMT-8, on bone loss and osteoclast structure and function in osteoporotic states.
    Sasaki T; Ohyori N; Debari K; Ramamurthy NS; Golub LM
    Ann N Y Acad Sci; 1999 Jun; 878():347-60. PubMed ID: 10415740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Laddec on the formation of calcified bone matrix in rat calvariae cells culture.
    Hofman S; Sidqui M; Abensur D; Valentini P; Missika P
    Biomaterials; 1999 Jul; 20(13):1155-66. PubMed ID: 10395384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracycline administration normalizes the structure and acid phosphatase activity of osteoclasts in streptozotocin-induced diabetic rats.
    Kaneko H; Sasaki T; Ramamurthy NS; Golub LM
    Anat Rec; 1990 Aug; 227(4):427-36. PubMed ID: 2168133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained osteoblast nuclear receptor binding of converted 1alpha, 25-dihydroxyvitamin D3 after administration of 3H-1alpha-hydroxyvitamin D3: a combined receptor autoradiography and radioassay time course study with comparison to 3H-1alpha, 25-dihydroxyvitamin D3.
    Koike N; Ichikawa F; Nishii Y; Stumpf WE
    Calcif Tissue Int; 1998 Nov; 63(5):391-5. PubMed ID: 9799823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electron microscopic study of the origin of osteoblasts in implants of demineralized bone matrix.
    Bombí JA; Ribas-Mujal D; Trueta J
    Clin Orthop Relat Res; 1978; (130):273-84. PubMed ID: 639401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural studies on the origin and structure of matrix vesicles in bone of young rats.
    Ornoy A; Atkin I; Levy J
    Acta Anat (Basel); 1980; 106(4):450-61. PubMed ID: 7386166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.
    Islam MM; Franco CD; Courtman DW; Bendeck MP
    Am J Pathol; 2003 Oct; 163(4):1557-66. PubMed ID: 14507662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term therapy with a new chemically modified tetracycline (CMT-8) inhibits bone loss in femurs of ovariectomized rats.
    Sasaki T; Ramamurthy NS; Golub LM
    Adv Dent Res; 1998 Nov; 12(2):76-81. PubMed ID: 9972126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 stimulates preosteoblast replication: an autoradiographic study in cultured fetal rat calvariae.
    Gronowicz GA; Fall PM; Raisz LG
    Exp Cell Res; 1994 Jun; 212(2):314-20. PubMed ID: 8187824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural cytochemistry of complex carbohydrates in osteoblasts, osteoid, and bone matrix.
    Takagi M; Parmley RT; Toda Y; Denys FR
    Calcif Tissue Int; 1983 May; 35(3):309-19. PubMed ID: 6871762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (clodronate) inhibits bone loss in the ovariectomized rat: a dynamic histomorphometric and gene expression study.
    Ramamurthy N; Bain S; Liang CT; Barnes J; Llavaneras A; Liu Y; Puerner D; Strachan MJ; Golub LM
    Curr Med Chem; 2001 Feb; 8(3):295-303. PubMed ID: 11172684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfabricated discontinuous-edge surface topographies influence osteoblast adhesion, migration, cytoskeletal organization, and proliferation and enhance matrix and mineral deposition in vitro.
    Hamilton DW; Wong KS; Brunette DM
    Calcif Tissue Int; 2006 May; 78(5):314-25. PubMed ID: 16604286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.